Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children

References

• Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030–1043.
   PubMed Web of Science ®Google Scholar
• Tallen G, Ratei R, Mann G, . Long term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J Clin Oncol 2010;28: 2339–2347.
   PubMed Web of Science ®Google Scholar
• Van den Berg H, de Groot-Kruseman HA, Damen-Korbijn CM, . Outcome after first relapse in children with acute lymphoblastic leukemia: a report based on the Dutch Childhood Oncology Group (DCOG) Relapse ALL98 protocol. Pediatr Blood Cancer 2011;57:210–216.
   PubMed Web of Science ®Google Scholar
• Malempati S, Gaynon PS, Sather H, . Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG 1952. J Clin Oncol 2007;25:5800–5807.
   PubMed Web of Science ®Google Scholar
• Nguyen K, Devidas M, Cheng S-C, . Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia 2008;22:2142–2150.
   PubMed Web of Science ®Google Scholar
• Balduzzi A, Galimberti S, Valsecchi MG, . Autologous purified peripheral stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse. Pediatr Blood Cancer 2011;57:654–659.
   PubMed Web of Science ®Google Scholar
• Borgmann A, von Stackelberg A, Hartmann R, . Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission:a matched-pair analysis. Blood 2003;101:3835–3839.
   PubMed Web of Science ®Google Scholar
• Lange BJ, Bostrom BC, Cherlow JM, . Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 2002;99:825–833.
   PubMed Web of Science ®Google Scholar
• Nachman J, Sather HN, Cherlow JM, . Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol 1998;16:920–930.
   PubMed Web of Science ®Google Scholar
• Pui C-H, Sandlund JT, Pei D, . Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy XIIIB at St. Jude Children's Research Hospital. Blood 2004;104:2690–2696.
   PubMed Web of Science ®Google Scholar
• Matloub Y, Bostrom BC, Hunger SP, . Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011;118:243–251.
   PubMed Web of Science ®Google Scholar
• Seibel NL, Steinherz PG, Sather HN, . Early post induction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008;111:2548–2555.
   PubMed Web of Science ®Google Scholar
• Pui C-H, Relling MV, Sandlund JT, . Rationale and design of Total XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol 2004;83(Suppl. 1):S124–S126.
   PubMed Web of Science ®Google Scholar
• Lawson SE, Harrison G, Richards S, . The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study. Br J Haematol 2000;108: 531–543.
   PubMed Web of Science ®Google Scholar
• Abshire TC, Pollock BH, Billett AL, . Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study. Blood 2000;96:1709–1715.
   PubMed Web of Science ®Google Scholar
• Raetz EA, Borowitz MJ, Devidas M, . Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol 2008;26:3971–3978.
   PubMed Web of Science ®Google Scholar
• Ko RH, Ji L, Barnette P, . Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol 2010;28:648–654.
   PubMed Web of Science ®Google Scholar
• Buchanan GR, Rivera GK, Boyett JM, . Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. Blood 1988;72:1286–1292.
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Harris RE, Altman AJ, . Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. 2006;24:3150–3156.
   Google Scholar
• Testi AM, Giudice AD, Arcese W, . A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood “high-risk” acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol 2002;118:741–747.
   PubMed Web of Science ®Google Scholar
• Einsiedel HG, von Stackelberg A, Hartmann R, . Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 2005;23:7942–7950.
   PubMed Web of Science ®Google Scholar
• Ritchey AK, Pollock BH, Lauer SJ, . Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1999;17:3745–3752.
   PubMed Web of Science ®Google Scholar
• Harker-Murray PD, Thomas AJ, Wagner JE, . Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Biol Blood Marrow Transplant 2008;14:685–692.
   PubMed Web of Science ®Google Scholar
• Rizzari C, Valsecchi MG, Arico M, . outcome of very late relapse in children with acute lymphoblastic leukemia. Haematologica 2004;89:427–434.
   PubMed Web of Science ®Google Scholar
• Rivera GK, Hudson MM, Liu Q, . Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. Blood 1996;88:831–837.
   PubMed Web of Science ®Google Scholar